Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trial
Author(s) -
Jessica W. Pawlowski,
Berdine R. Martin,
George P. McCabe,
Linda McCabe,
George S. Jackson,
Munro Peacock,
Stephen Barnes,
Connie M. Weaver
Publication year - 2015
Publication title -
american journal of clinical nutrition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.608
H-Index - 336
eISSN - 1938-3207
pISSN - 0002-9165
DOI - 10.3945/ajcn.114.093906
Subject(s) - equol , daidzein , isoflavones , glycitein , genistein , calcium , crossover study , medicine , phytoestrogens , endocrinology , chemistry , estrogen , placebo , alternative medicine , pathology
Postmenopausal estrogen depletion is a major contributing factor to bone loss. Soy isoflavones have variable effects on the prevention of postmenopausal bone loss, which is possibly related to the specific isoflavone content or the variable equol-producing capacity of individuals.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom